CULLINAN THERAPEUTICS, INC. (CGEM) Operating income 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual operating income history from SEC filings — each fiscal year as reported.
-$241.6MFY2025 · since FY2020: -$60.3M → -$241.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.6M | -22.7% |
| FY2024 | -$196.9M | -3.1% |
| FY2023 | -$191.1M | -232.1% |
| FY2022 | $144.6M | +312.9% |
| FY2021 | -$68.0M | -12.6% |
| FY2020 | -$60.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGEM financial trends
CGEM RevenueCGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating marginCGEM Operating cash flowCGEM Free cash flowCGEM Capital expendituresCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →